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Mammalian oxygen sensing, signalling and gene regulation
Abstract
Oxygen is essential to the life of all aerobic organisms. Virtually every cell type is able to sense a
limited oxygen supply (hypoxia) and specifically to induce a set of oxygen-regulated genes. This review
summarizes current concepts of mammalian oxygen-sensing and signal-transduction pathways. Since
the discovery of the hypoxia-inducible factors (HIFs), a great deal of progress has been made in our
comprehension of how hypoxia induces the expression of oxygen-regulated genes. The alpha subunit of
the heterodimeric transcription factors HIF-1, 2 and 3 is unstable under normoxia but is rapidly
stabilized upon exposure to hypoxic conditions. Following heterodimerization with the constitutively
expressed beta subunit, HIFs activate the transcription of an increasing number of genes involved in
maintaining oxygen homeostasis at the cellular, local and systemic levels.
An adequate supply of oxygen is essential to all higher
organisms because it serves as the terminal electron acceptor
in mitochondrial oxidative phosphorylation and because
several enzymatic processes require molecular oxygen as a
substrate. Even slight reductions in normal oxygen
concentrations (hypoxia) can cause the induction of specific
genes involved in mammalian oxygen homeostasis such as
erythropoietin or vascular endothelial growth factor (VEGF).
Investigations of such hypoxia-inducible genes performed in
many different cultured cell lines suggest that every
mammalian (perhaps even every vertebrate and insect) cell
possesses one or several oxygen-sensing mechanism(s), i.e. a
molecular oxygen sensor. Certain cell types, which can be
found in carotid bodies, airway neuroepithelial bodies and
pulmonary arteries, have differentiated into specialized
oxygen-sensing cells. However, the mammalian cellular
oxygen sensor is not known. The beautifully elaborated
principles of oxygen sensing in bacteria and yeast (for a
review, see Bunn and Poyton, 1996) have still to find their
counterparts in higher organisms. In the nitrogen-fixing
bacterium Bradyrhizobium japonicum, for instance, the oxygen
sensor is a histidine kinase termed FixL which, under
anaerobic conditions, phosphorylates and thereby activates the
transcription factor FixJ. Interestingly, the oxygen-sensing
domain of FixL is a so-called PAS domain (see below), a
versatile protein fold resembling a left-handed glove that
encloses a haem cofactor (Gong et al., 1998). When oxygen is
bound to ferrous (FeII) haem, this domain is in the flattened
‘off’ state, resulting in a change in the protein conformation
and inactivation of the kinase domain.
The haem oxygen sensor hypothesis
So far, virtually all proteins capable of binding molecular
oxygen contain iron, usually in the centre of a haem moiety.
Thus, it came as no surprise when, in 1988, Bunn and co-
workers suggested that the mammalian oxygen sensor could be
a haem protein (Goldberg et al., 1988). Apart from hypoxia,
cobalt (and to a lesser extent nickel and manganese) salts were
capable of inducing erythropoietin gene expression with no
additional effects under hypoxic conditions, indicating that
ferrous haem iron was replaced by the non-oxygen-binding
cations. According to the model, this locks the oxygen sensor
in the deoxy conformation. Moreover, carbon monoxide
inhibited hypoxic but not cobalt-mediated activation of
erythropoietin gene expression, in line with the known
properties of carbon monoxide binding to haemoglobin.
Blockers of haem synthesis abolished both hypoxic and cobalt-
dependent erythropoietin induction. Further evidence for the
haem hypothesis was provided by the finding that iron
chelators, such as desferrioxamine, are also capable of
mimicking hypoxia (Ho and Bunn, 1996; Wang and Semenza,
1993b).
Although the basic findings that led to the hypothesis of a
haem oxygen sensor responsible for hypoxic erythropoietin
induction have been confirmed for many other hypoxia-
inducible genes, several discrepancies remain. For example,
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Oxygen sensing
differential effects of the flavoprotein inhibitor diphenylene
iodonium on hypoxia-induced versus cobalt-induced gene
expression have been reported. Ratcliffe and co-workers found
that 50 nmol l- 1 and 1 m mol l- 1 diphenylene iodonium inhibited
hypoxic but not cobalt- or iron-chelator-dependent induction
of several oxygen-regulated genes (Gleadle et al., 1995). In
striking contrast, Goldwasser et al. (1995) demonstrated a 50 %
inhibition of cobalt chloride but not of hypoxic erythropoietin
induction by 30 nmol l - 1 diphenylene iodonium. Schumacker
and co-workers reported that diphenylene iodonium and two
other mitochondrial inhibitors (rotenone and myxothiazol)
blocked hypoxic but not cobalt-dependent induction of
erythropoietin mRNA (Chandel et al., 1998). Ratcliffe and co-
workers (Gleadle et al., 1995) and Semenza and co-workers
(Agani and Semenza, 1998) also showed that the flavoprotein
cytochrome P450 reductase inhibitor mersalyl inhibited
hypoxia-, cobalt-chloride- and desferrioxamine-dependent
induction of the erythropoietin gene. However, mersalyl
induced the hypoxia-inducible factor-1a (HIF-1a , see below)
and the vascular endothelial growth factor (VEGF) gene
(Agani and Semenza, 1998). Mersalyl also induced a reporter
gene under the control of transferrin-derived hypoxia-
responsive elements (Rolfs et al., 1997) under normoxia
without any further effects under hypoxia (R. Wanner and R.
H. Wenger, in preparation). Finally, following careful titration
of oxygen and cobalt chloride concentrations (taking into
consideration that the optimal concentration of the toxic agent
cobalt chloride is itself a function of the oxygen concentration),
we found that there might well be additive effects on
erythropoietin induction when both agents were applied
simultaneously (Wenger et al., 1998b).
In summary, these discrepancies suggest either that hypoxia,
cobalt and desferrioxamine interact with different steps along
the oxygen signal-transduction pathway or that they each affect
additional pathways that cross-talk with the oxygen pathway.
These contradictory reports also reflect the difficulties of using
pleiotropic agents to track down the oxygen sensor to its
molecular entity. Different effects of these agents depending
on concentration, target genes and cell types have to be
considered. Nevertheless, the haem hypothesis is still the best
model available. But what kind of haem protein is it?
Many candidates – no election
Because there is no assay available to identify directly the
oxygen sensor among the hundreds of known oxygen-binding
proteins, many different candidate proteins have been
suggested in the past to play this role as a sensor in addition
to their known or proposed functions. The following section
will provide some examples and discuss briefly the pros and
cons for their putative role in oxygen sensing.
One of the most often cited putative haem oxygen-sensing
molecules is the cytochrome b558/NADPH oxidase complex
that generates superoxide in the plasma membrane of
phagocytes and B lymphocytes. The subunits of this complex
have also been found in cells of non-immunological origin,
including hepatoma cell lines (Görlach et al., 1993, 1994),
small cell lung carcinoma (Wang et al., 1996) and
pheochromocytoma PC12 cells (Hohler et al., 1999), and in
oxygen-sensing cells of the carotid body (the arterial
chemoreceptor; Acker et al., 1989; Cross et al., 1990; Kummer
and Acker, 1995; Lahiri et al., 1999) and pulmonary
neuroepithelial bodies (the airway chemoreceptors; Wang et
al., 1996; Youngson et al., 1993, 1997). Therefore, Acker and
co-workers put forward the hypothesis that the b558 complex
may serve as an oxygen sensor (for a review, see Acker, 1994).
However, we have demonstrated normal oxygen-regulated
gene expression in cell lines derived from patients suffering
from chronic granulomatous disease, an inherited disease in
which one of the subunits of the b558/NADPH oxidase complex
is defective (Wenger et al., 1996). Our conclusion that this
complex is not likely to be the ‘universal’ oxygen sensor has
recently been confirmed in knock-out mice deficient in the
gp91phox subunit of the b558/NADPH oxidase complex (Archer
et al., 1999). Despite a marked reduction in superoxide
production, hypoxia caused similar levels of pulmonary
vasoconstriction and inhibition of whole-cell K+ current in
both knock-out and wild-type mice.
Another apparently promising candidate oxygen sensor is
the principal oxygen-consuming organelle of the cell, the
mitochondrion itself. Because the respiratory electron transport
chain blocker potassium cyanide cannot induce erythropoietin
gene expression, mitochondria were soon ruled out as the
oxygen sensor (Goldberg et al., 1988; Tan and Ratcliffe,
1991). Nevertheless, Lahiri and co-workers proposed that
mitochondrial cytochrome a3 (Lahiri et al., 1995; Wilson et al.,
1994) and Schumacker and co-workers suggested that
mitochondrial cytochrome c oxidase (Chandel et al., 1997)
could serve as the oxygen sensor. Interestingly, depleting cells
of mitochondrial DNA ( r 0 cells) and treatment with several
mitochondrial inhibitors blocked hypoxic induction of oxygen-
regulated genes (Chandel et al., 1998). However, because
potassium cyanide does not interfere with hypoxic induction
of HIF-1 a (Jiang et al., 1996), the role of mitochondria in
oxygen sensing remains unclear.
Various enzymatic processes that result in the production of
different second-messenger molecules are catalyzed by haem
proteins. For instance, the guanylate cyclase and cytochrome
P450 of the 4A family, producing cyclic GMP (cGMP) and 20-
hydroxyeicosatetraenoic acid (20-HETE), respectively, have
been proposed as oxygen sensors (Harder et al., 1996; Taylor
et al., 1998). Cytochrome P450 (ant)agonists have also been
shown to modulate erythropoietin expression (Fandrey et al.,
1990), but the involvement of cytochrome P450 could not be
confirmed by spectrophotometric analysis (Ehleben et al.,
1998).
What next?
As outlined above, the ‘comparative approach’ to the
identification of the oxygen sensor is biased by our limited
knowledge of the function and the number of candidate haem
proteins. There may be many more candidates since a haem
protein cannot be recognized easily from its primary amino
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acid sequence. What would be an unbiased ‘empirical
approach’ to this problem? Oxygen binding is not a sufficient
criterion for the sensor; it must connect an oxygen-dependent
enzymatic activity (many of which are already known) to the
regulation of hypoxia-inducible genes. Therefore, only the
inactivation of the (unknown) sensor and an analysis of the
consequences on gene activation can serve to identify it
unambiguously. Ratcliffe and co-workers used hypoxia-
response elements to direct the expression of reporter genes.
Following random mutagenesis, cells were selected that had
lost the ability for oxygen-regulated gene expression. This
approach has been validated by the identification of an HIF-1a
inactivation mutation (Wood et al., 1998). The oxygen sensor,
however, remained unidentified.
Oxygen signalling
The reactive oxygen species dilemma
Reactive oxygen species (ROS) such as superoxide and
peroxide are known to serve as signal transducers in several
systems (for a review, see Suzuki et al., 1997). Because oxygen
is the main component of these molecules, it seems obvious
that their concentration depends upon the environmental
oxygen concentration. Fandrey, Jelkmann and co-workers
reported a close relationship between oxygen and hydrogen
peroxide concentrations and rates of erythropoietin production
in hepatoma cells (Fandrey et al., 1994). Hydrogen peroxide
sequestration could mimic hypoxia (Canbolat et al., 1998) and
addition of hydrogen peroxide inhibited hypoxic induction of
erythropoietin (Fandrey et al., 1994). This inhibition could be
reversed by cobalt chloride and iron chelation (Fandrey et al.,
1997). These findings have been confirmed for the oxygen-
regulated genes encoding tyrosine hydroxylase (Kroll and
Czyzyk-Krzeska, 1998) and several enzymes involved in
glucose metabolism (Kietzmann et al., 1996, 1997). This
model is also compatible with the idea that the thiol reducing
agent N-(2-mercaptopropionyl)-glycine and the oxygen radical
scavenger 2-acetamidoacrylic acid, but not many other
antioxidants, could mimic hypoxia by inducing HIF-1 a under
normoxic conditions (Chilov et al., 1999; Salceda and Caro,
1997).
Enzymes generating ROS, such as the cytochrome b558/
NADPH oxidase complex (see above), have been proposed as
the source for superoxide, which is rapidly converted into
peroxide by superoxide dismutase. Acker and co-workers
suggested a localized Fenton reaction in perinuclear cytosolic
granules containing high iron concentrations (Kietzmann et al.,
1998; Porwol et al., 1998). The Fenton reaction describes the
non-enzymatic reduction of hydrogen peroxide to a hydroxyl
anion and the highly reactive hydroxyl radical by oxidation of
the ferrous iron. This model would separate the sites of oxygen
sensing and the effects of cobalt/iron chelation, and it would
explain the differences observed in the function of these
agents. According to this hypothesis, normoxic hydroxyl
radical concentrations would inactivate HIF-1a , which is
relieved from suppression following a decrease in radical
concentrations under hypoxic conditions. A prototype factor
for such a mechanism is the iron regulatory protein 2, which
is oxidized in an oxygen-dependent manner, ubiquitinated and
degraded by the proteasomes in iron-replete cells (Iwai et al.,
1998).
In striking contrast to these findings, Schumacker and co-
workers reported that cardiomyocytes increase their production
of ROS following exposure to hypoxia (Duranteau et al., 1998;
Vanden Hoek et al., 1998). Antioxidants inhibited this increase
in levels of ROS and also blocked hypoxic inhibition of
cardiomyocyte contraction. The mitochondrial cytochrome c
oxidase was suggested as the oxygen sensor that enhanced
ROS production in hypoxic cardiomyocytes (Budinger et al.,
1998) and hepatocytes (Chandel et al., 1997). Support for this
model was provided by using hepatoma cells depleted of
functional mitochondria ( r 0 cells), which showed no induction
of ROS under hypoxia and which failed to induce oxygen-
regulated gene expression (Chandel et al., 1998).
Taken together, there is no common consensus about
whether ROS concentrations decrease or increase following
exposure to acute hypoxia. Further experiments determining
the kinetics and dependence on oxygen concentration of ROS
production will be required to obtain a more definitive picture.
Alternative or no second messengers?
Apart from ROS, other metabolic processes occurring
during hypoxia could potentially serve to sense and signal the
cellular oxygenation state. A decrease in pH as a consequence
of lactate production by anaerobic glycolysis might be
responsible for hypoxic gene induction. The hypoxia-induced
increase in ferritin production, for instance, might be regulated
by iron release from ferritin as a result of acidification of the
cytoplasm (Qi et al., 1995). Similarly, hypoxic induction of the
p53 tumour suppressor protein has been reported to be
dependent on acidosis (Schmaltz et al., 1998). However, a
significant decrease in pH requires prolonged or severe
hypoxia (anoxia) rather than the short periods of hypoxia
sufficient to induce HIF-1a . Indeed, we have observed no
effects of altered pH on oxygen-regulated gene expression (A.
Rolfs and R. H. Wenger, unpublished observations). In
general, it is difficult to understand how signal transducers
such as ROS, redox state, pH, ATP, cAMP/cGMP or adenosine
could trigger the ubiquitous, sensitive, specific and very rapid
hypoxic induction of gene expression. A specific sensor that
signals directly to HIF-1 and/or its degradation machinery
seems to be more appropriate to fulfil these tasks.
The hypoxia-inducible factors
Compared with the relative lack of information on the
oxygen sensor and its signal-transduction pathway, much more
is known about the target of these putative signalling
mechanisms. In 1995, Semenza and co-workers discovered
HIF-1 on the basis of its ability to bind to a hypoxia-response
element (HRE) in the 3 ¢ flanking region of the erythropoietin
gene (Wang et al., 1995a). HIF-1 is a ubiquitously and
constitutively expressed heterodimeric transcription factor
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composed of an a subunit unstable under normoxia and a
common b subunit, the latter being shared by other
transcription factors (for reviews, see Bunn and Poyton, 1996;
Semenza, 1998; Wenger and Gassmann, 1997). HIF-1 b had
previously been identified as the heterodimerization partner of
the dioxin receptor/aryl hydrocarbon receptor (AhR) and was
hence called AhR nuclear translocator (ARNT, see Hoffman et
al., 1991). HIF-1 a heterodimerization with ARNT in the
nucleus is required for DNA binding and transactivation
(Gassmann et al., 1997; Gradin et al., 1996; Kallio et al., 1997;
Salceda et al., 1996; Wood et al., 1996) but not for
translocation into the nucleus (Chilov et al., 1999; Kallio et al.,
1998).
The most intriguing feature of HIF-1a is a so-called oxygen-
dependent degradation domain (ODD) that can confer hypoxic
stabilization to HIF-1a and to various fusion partner proteins
(Huang et al., 1998; Pugh et al., 1997; Srinivas et al., 1999a).
Under normoxic conditions, this domain seems to receive a
signal that primes the HIF-1a protein for ubiquitination and
subsequent degradation in proteasomes. In fact, HIF-1a protein
is usually undetectable under normoxic conditions. Proteasomal
inhibitors or mutation of the ubiquitin-activating enzyme E1
stabilize the HIF-1a protein but fail to induce oxygen-regulated
gene expression (Huang et al., 1998; Kallio et al., 1999; Salceda
and Caro, 1997). Normoxic HIF a subunit degradation involves
the von-Hippel–Lindau tumour suppressor protein (pVHL)
which recognizes and links HIF a subunits, via a complex
composed of several incompletely characterized proteins, to the
ubiquitination machinery (Maxwell et al., 1999). Cells deficient
in functional pVHL show constitutively high HIF a subunit
levels and expression of many oxygen-regulated genes, leading
to haemangioblastoma tumour formation.
The signal that primes the ODD domain for degradation is
not known. Reduction–oxidation (redox) reactions might be
involved in normoxic HIF-1 a degradation, as is the case for
other proteins such as iron regulatory protein 2 (Iwai et al.,
1998). Certain antioxidants and suppression of the Fenton
reaction by iron-chelation can induce HIF-1a protein as well
as HIF-1-dependent reporter gene activation (Huang et al.,
1996; Salceda and Caro, 1997). However, oxidation of HIF-
1a has not been demonstrated so far. Thus, it is not known
whether this is a specific mechanism linking HIF-1 a to the
oxygen sensor or whether the experimental data obtained are
the result of nonspecific processes and/or cross-talk with other
signal-transduction pathways. It is an intriguing possibility that
the autonomous ODD domain of HIF-1 a might sense oxygen
directly. This hypothesis would predict an iron-containing
oxygen-binding domain, either as a haem protein or as an
iron–sulphur cluster. However, we (P. Spielmann, F. Parpan
and R. H. Wenger, unpublished observations) and others
(Srinivas et al., 1999b) could not detect iron in bacterially
expressed fragments of HIF-1a that contain the ODD domain.
Although phosphorylation seems to play an important role
in the activation of HIF-1 a (Salceda et al., 1997; Wang et al.,
1995b), replacement of potential phosphoacceptor sites in the
critical region of the ODD domain had no effect on its activity
(Pugh et al., 1997; Srinivas et al., 1999a). Two recent reports
showed that the p42/p44 mitogen-activated protein kinases
(MAPKs) can phosphorylate the HIF a subunits, giving it
electrophoretic migration properties similar to those of the
hypoxically modified protein (Conrad et al., 1999; Richard et
al., 1999). However, the phosphorylated amino acid residues
have not been identified. MAPK-dependent phosphorylation
enhances the transcriptional activity of HIFs, but in non-
excitable cells the p42/p44 MAPKs are not activated by
hypoxia (Richard et al., 1999). In excitable cells, hypoxia
might indirectly activate MAPKs, but HIF a protein
stabilization is not related to MAPK-dependent
phosphorylation (Conrad et al., 1999). Thus, p42/p44 MAPKs
do not account for the most critical step in HIF a subunit
activation: the stabilization of the ODD domain.
HIF-1 a contains two transactivation (TA) domains, one
overlapping with the ODD domain and the second at the C
terminus (Huang et al., 1998; Jiang et al., 1997; Li et al., 1996;
Pugh et al., 1997). Apart from conferring protein stabilization,
these transactivation domains might be further activated under
hypoxic conditions (Kallio et al., 1998), for example via
p42/p44 MAPK-dependent phosphorylation (Conrad et al.,
1999; Richard et al., 1999) or redox-dependent processes
(Huang et al., 1996; Salceda and Caro, 1997). A reductive
environment provided by the redox factor Ref-1 enhances the
recruitment of the transcriptional coactivators SRC-1, TIF2
and CBP/p300 (Carrero et al., 2000). Fujii-Kuriyama and co-
workers identified a redox-sensitive conserved cysteine
residue, mutation of which inhibited the transactivation
function (Ema et al., 1999). These authors proposed a model
in which reduced thioredoxin translocates into the nucleus of
hypoxic cells and transfers the redox signal to Ref-1 which, in
turn, interacts with this cysteine. Indeed, overexpression of
thioredoxin/Ref-1 has been shown previously to amplify the
hypoxic signal (Huang et al., 1996). However, the functional
importance of this cysteine residue could not be confirmed in
other mutation experiments (O’Rourke et al., 1999), and we
did not observe nuclear translocation of thioredoxin under
hypoxia (U. Alt and R. H. Wenger, unpublished observations).
Therefore, the specificity of thioredoxin/Ref-1 in maintaining
HIF-1 a in a reduced state as part of the hypoxia-signalling
mechanism awaits further clarification.
Apart from the ubiquitously expressed HIF-1a , two other
members of this family, HIF-2a (Ema et al., 1997; Flamme et
al., 1997; Hogenesch et al., 1997; Tian et al., 1997) and HIF-3a
(Gu et al., 1998), have been identified which show a more
restricted expression pattern. Functional comparison between
HIF-1a and HIF-2a in vitro revealed many similarities
concerning genomic organization, modular protein structure,
hypoxic protein stabilization, heterodimerization, DNA binding
and the transactivation function of reporter genes (Ema et al.,
1999; Hogenesch et al., 1998; Maxwell et al., 1999; O’Rourke et
al., 1999; Wenger et al., 1997; Wiesener et al., 1998). In vivo
gene targeting (knock-out) experiments in mice showed that HIF-
1a is required for mesenchymal cell survival during embryonic
development: knock-out animals die around midgestation,
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showing cardiovascular malformations and open neural tube
defects (Iyer et al., 1998; Kotch et al., 1999; Ryan et al., 1998).
Mice containing only one mutant HIF-1a allele develop normally
but show impaired physiological responses to chronic hypoxia
(Yu et al., 1999). Interestingly, in HIF-2a knock-out embryos,
the organ of Zuckerkandl (the major catecholamine source during
development) does not produce sufficient amounts of
catecholamines, leading to embryonic lethality presumably
because of bradycardia (Tian et al., 1998). The expression pattern
and functional role of HIF-3a have still to be elucidated.
The PAS family of transcription factors and sensors
Another interesting feature of the HIF a subunits is the
presence of PAS domains which can also be found in
mammalian ARNT1, 2 and 3 and in their corresponding
heterodimerization partners (HIF-1 a , 2 a , 3a , AhR1, 2 and
CLOCK) as well as in several other transcription factors
including Per1, 2, Sim1, 2 and NPAS1, 2 and 3 (for a review,
see Taylor and Zhulin, 1999). PAS is an acronym standing for
the first family members known: Per, AhR/ARNT and Sim.
Most of these PAS proteins have been cloned from mammalian
and fish species and from Drosophila, where they play
important roles in various aspects of development, oxygen
homeostasis and circadian rhythm.
Most of the PAS domain proteins described to date have
been found in the Bacteria and Archea kingdoms, where they
often serve as sensors of oxygen levels, redox state or light
levels. Intriguingly, the haem-containing pocket of the FixL
oxygen sensor is a PAS domain (Gong et al., 1998), and it is
tempting to speculate that the HIF-1a PAS domain displays
similar features. However, haem binding to the PAS domain
has never been detected, and it is unlikely that HIF-1a
functions by itself as an oxygen sensor. In Eukarya, the PAS
domain has apparently evolved to a heterodimerization
interface that is usually preceded by a basic helix–loop–helix
DNA-binding and heterodimerization domain. Whether
functionally altered or not, it is astonishing that this domain is
conserved in proteins of higher organisms that are functionally
related to their predecessors in more primitive species.
Oxygen-regulated gene expression
HIF-1-mediated gene activation
Once activated by hypoxia, HIF-1 binds to the consensus
HIF-1 DNA binding site (HBS) A/(G)CGTG present in the
hypoxia-response elements (HREs) of many oxygen-regulated
genes (for a review, see Wenger and Gassmann, 1997). In the
erythropoietin gene, this site can also be constitutively bound
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Table 1. Identified HIF-1 target genes
Hypoxia-inducible HIF-1 target gene References
Oxygen transport: erythropoiesis
Erythropoietin Firth et al. (1994); Semenza et al. (1994); Wang and Semenza (1993a)
Transferrin (iron transport) Rolfs et al. (1997)
Transferrin receptor (iron uptake) Lok and Ponka (1999); Tacchini et al. (1999)
Oxygen transport: angiogenesis and vascular tone
Vascular endothelial growth factor (VEGF) Forsythe et al. (1996); Levy et al. (1995); Liu et al. (1995)
Flt-1 (VEGF receptor 1)* Gerber et al. (1997)
Plasminogen activator inhibitor-1 Kietzmann et al. (1999)
Endothelin-1* Hu et al. (1998)
Inducible nitric oxide synthase (NO production) Melillo et al. (1995); Palmer et al. (1998)
Haem oxygenase 1 (CO production) Lee et al. (1997)
Adrenomedullin Nguyen and Claycomb (1999)
a 1B-Adrenergic receptor Eckhart et al. (1997)
Anaerobic energy: glycolysis and glucose uptake
Phosphofructokinase L Semenza et al. (1994)
Aldolase A Semenza et al. (1994, 1996)
Glyceraldehyde-3-phosphate dehydrogenase Graven et al. (1999)
Phosphoglycerate kinase 1 Firth et al. (1994); Okino et al. (1998); Semenza et al. (1994, 1996)
Enolase 1 Semenza et al. (1994, 1996)
Lactate dehydrogenase A Firth et al. (1995)
Glucose transporter-1 Ebert et al. (1995); Okino et al. (1998)
Negative feedback regulation of HIF-1 function
p35srj (CBP/p300 antagonist) Bhattacharya et al. (1999)
Others
Insulin-like growth factor binding protein-1 Tazuke et al. (1998)
Retrotransposon VL30 Estes et al. (1995)
HIF, hypoxia-inducible factor; CBP/p300, a transcriptional coactivator with histone acetyltransferase activity.
by the transcription factors activating transcription factor-1
(ATF-1) and cAMP-responsive element-binding-1 (CREB-1)
(Kvietikova et al., 1995, 1997). Normoxic occupancy of the
HBS (Hu et al., 1997) might protect the CpG dinucleotide
present in the HBS from becoming methylation-inactivated






























































Fig. 1. Hypothetical model of oxygen sensing, signalling and gene regulation. Under hypoxic conditions, the ODD/TA domain of HIF-1a (blue) is
stable and allows nuclear translocation and gene regulation. Under normoxic conditions, the ODD/TA domain (orange) obtains a signal from an
unknown oxygen sensor which targets HIF-1a for proteolytic degradation via ubiquitination by an incompletely characterized complex containing
the pVHL tumour suppressor protein. See text for details. ARNT, aryl hydrocarbon receptor (AhR) nuclear translocator; bHLH, basic-helix-loop-
helix; CBP, CREB binding protein (CBP and p300 are two related transcriptional coactivators with histone acetyltransferase activity); Cul2, cullin
2; E2, unknown ubiquitin-conjugating enzyme; HBS, HIF-1 binding site; HRE, hypoxia-response element; ODD, oxygen-dependent degradation
domain; PAS, Per-AhR/ARNT-Sim domain (see text); pol II, RNA polymerase II; pVHL, von-Hippel-Lindau tumour suppressor protein; Rbx1, a
RING-H2 finger protein; TA, transactivation domain; Ub, ubiquitin; +1 indicates the transcriptional start site.
the two transactivation domains of HIF-1a as well as the C-
terminal transactivation domain of ARNT transcriptional
coactivators including the histone acetyltransferases CBP/p300
(Arany et al., 1996; Ebert and Bunn, 1998; Ema et al., 1999;
Kallio et al., 1998) and SRC-1 and TIF2 (Carrero et al., 2000).
It should be noted that an HBS is necessary, but not
sufficient, for efficient gene activation. Binding of other
transcription factors in the vicinity of HIF-1 or multimerization
of HBSs is usually observed. In the erythropoietin HRE, for
example, an unknown factor binding to a CACA box plus the
hepatocyte nuclear factor-4 are required to form a functional
transcriptional complex (Galson et al., 1995). Other examples
include cooperation with the ATF-1/CREB-1 factor in the
lactate dehydrogenase A gene (Ebert and Bunn, 1998; Firth et
al., 1995) or with activator protein-1 (AP-1) binding factors in
the VEGF gene (Damert et al., 1997). Alternatively, we found
two adjacent HBSs in the transferrin enhancer (Rolfs et al.,
1997), and two or three adjacent HBSs were also found in the
genes for phosphoglycerate kinase 1, enolase 1, lactate
dehydrogenase A, glucose transporter-1, haem oxygenase 1,
p35srj and insulin-like growth factor binding protein-1
(IGFBP-1) (for references, see Table 1).
Several negative feedback regulatory pathways apparently
exist to limit the hypoxic response. At the level of mRNA, we
found a downregulation of HIF-1a mRNA concentrations by
an unknown mechanism following prolonged exposure to
hypoxia (Wenger et al., 1998c). At the transactivation level,
HIF-1-dependent induction of p35srj has been reported, which
in turn binds to the critical coactivator CBP/p300 and blocks
the interaction with HIF-1a , resulting in a marked inhibition
of transactivation (Bhattacharya et al., 1999).
HIF-1 target genes
Table 1 shows a compilation of the HIF-1 target genes
identified so far. Only genes where functional HIF-1 DNA-
binding or transactivation has been demonstrated are listed.
These genes are involved in oxygen homeostasis at the cellular,
local and systemic levels. Erythropoietin activates
erythropoiesis to enhance the systemic oxygen transport
capacity. Because iron is a limiting factor in haem formation,
erythropoiesis is sustained by increased expression of
transferrin and transferrin receptor to enhance iron supply to
erythroid cells.
At the local level, HIF-1 activates vascular endothelial
growth factor, as well as one of its receptors (Flt-1), which
induce angiogenesis leading to an increase in the vascular
density and hence a decrease in the diffusion distance for
oxygen. Local blood circulation is also controlled by
modulation of the vascular tone through the production of NO
(nitric oxide synthase), CO (haem oxygenase 1), endothelin-1,
adrenomedullin or activation of the a 1B-adrenergic receptor. It
is notable that HIF-1 binding to the HREs of the endothelium-
specific genes Flt-1 and endothelin-1 has not been directly
demonstrated, and it seems possible that the relatively
endothelium-specific HIF-2 might regulate these genes.
At the cellular level, loss of ATP production in mitochondria
is compensated by anaerobic glycolysis. Therefore, glucose
uptake (glucose transporters) and glycolysis (glycolytic
enzymes, see Table 1) are upregulated by HIF-1. Besides
hypoxia, both insulin and insulin-like growth factors (IGF)-1
and 2 induce HIF-1 a expression (Agani and Semenza, 1998;
Feldser et al., 1999; Zelzer et al., 1998). In addition to glucose
transporters and glycolytic enzymes, HIF-1 activates IGF-2
and the IGF-binding proteins (IGFBPs) 1, 2 and 3 but not 4, 5
and 6 (Feldser et al., 1999; Tazuke et al., 1998). Other
pleiotropic growth factors and cytokines capable of inducing
HIF-1 include epidermal growth factor, fibroblast growth
factor-2, interleukin-1 b and tumour necrosis factor- a (Feldser
et al., 1999; Hellwig-Burgel et al., 1999). Thus, these results
indicate a complex interplay between positive and negative
regulatory growth factors, although further experiments are
required to provide a more detailed picture.
Concluding remarks
Fig. 1 summarizes schematically the current models and
hypotheses about how a cell senses, signals and reacts to
reductions in oxygen concentration. The identification of the
oxygen sensor and the corresponding signal-transduction
pathway that leads to the activation of HIFs will be of principal
research interest for the near future. With regard to the
importance of hypoxia in many major diseases (cardiovascular
defects, tumour growth), the findings will be of major
importance for the treatment of these diseases.
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